{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=three+times+weekly+Epo", "query": { "intervention": "three times weekly Epo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 31, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=three+times+weekly+Epo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-01T02:07:39.216Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00077610", "title": "A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Epoetin alfa or beta", "type": "DRUG" }, { "name": "RO0503821 (1x/2 Weeks)", "type": "DRUG" }, { "name": "RO0503821 (1x/4 Weeks)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 673, "start_date": "2004-02", "completion_date": "2005-08", "has_results": true, "last_update_posted_date": "2017-01-13", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Encino", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00077610" }, { "nct_id": "NCT01975818", "title": "Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Renal Insufficiency, Chronic" ], "interventions": [ { "name": "Molidustat (BAY 85-3934)", "type": "DRUG" }, { "name": "Epoetin alfa/beta", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2013-10-28", "completion_date": "2015-12-15", "has_results": false, "last_update_posted_date": "2019-09-20", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 30, "location_summary": "Azusa, California • Long Beach, California • Los Angeles, California + 21 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975818" }, { "nct_id": "NCT04313153", "title": "Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Vadadustat", "type": "DRUG" }, { "name": "Darbepoetin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 319, "start_date": "2020-05-27", "completion_date": "2022-06-22", "has_results": true, "last_update_posted_date": "2025-05-22", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 39, "location_summary": "Chula Vista, California • Granada Hills, California • Los Angeles, California + 31 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04313153" }, { "nct_id": "NCT05265325", "title": "A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Anemia" ], "interventions": [ { "name": "AND017 capsules TIW", "type": "DRUG" }, { "name": "AND017 capsules QW", "type": "DRUG" }, { "name": "epoetin alfa, darbepoetin alfa, Mircera®, or their biosimilars", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kind Pharmaceuticals LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2023-05-03", "completion_date": "2024-04-25", "has_results": false, "last_update_posted_date": "2024-06-28", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 10, "location_summary": "Pine Bluff, Arkansas • Riverside, California • Lone Tree, Colorado + 5 more", "locations": [ { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Riverside", "state": "California" }, { "city": "Lone Tree", "state": "Colorado" }, { "city": "Dalton", "state": "Georgia" }, { "city": "Gallup", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05265325" }, { "nct_id": "NCT01378273", "title": "Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Extreme Prematurity" ], "interventions": [ { "name": "Epo", "type": "DRUG" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "24 Weeks", "maximum_age": "27 Weeks", "sex": "ALL", "summary": "24 Weeks to 27 Weeks" }, "enrollment_count": 941, "start_date": "2013-12", "completion_date": "2020-02-28", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Gainesville, Florida • Miami, Florida + 14 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01378273" }, { "nct_id": "NCT03400033", "title": "Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anaemia" ], "interventions": [ { "name": "Daprodustat tablets", "type": "DRUG" }, { "name": "Matching placebo tablets", "type": "DRUG" }, { "name": "Epoetin alfa vials", "type": "DRUG" }, { "name": "Saline vials or bags", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 407, "start_date": "2018-09-05", "completion_date": "2020-06-19", "has_results": true, "last_update_posted_date": "2021-07-12", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 23, "location_summary": "Mesa, Arizona • Fresno, California • Los Angeles, California + 19 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Middlebury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03400033" }, { "nct_id": "NCT01628107", "title": "A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Renal Failure Requiring Hemodialysis" ], "interventions": [ { "name": "Epoetin Hospira", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 406, "start_date": "2012-07-16", "completion_date": "2015-01-02", "has_results": true, "last_update_posted_date": "2018-07-19", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 108, "location_summary": "Azusa, California • Bellflower, California • Commerce, California + 57 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Bellflower", "state": "California" }, { "city": "Commerce", "state": "California" }, { "city": "Cudahy", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01628107" }, { "nct_id": "NCT01235923", "title": "Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Preterm Infants" ], "interventions": [ { "name": "three times weekly Epo", "type": "DRUG" }, { "name": "weekly Epo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "100 Days", "sex": "ALL", "summary": "7 Days to 100 Days" }, "enrollment_count": 20, "start_date": "2006-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2022-06-21", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01235923" }, { "nct_id": "NCT03263091", "title": "Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)", "Anemia" ], "interventions": [ { "name": "Roxadustat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyntra Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 184, "start_date": "2018-01-29", "completion_date": "2023-06-20", "has_results": true, "last_update_posted_date": "2024-08-01", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 30, "location_summary": "Bakersfield, California • Beverly Hills, California • Burbank, California + 25 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Laguna Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03263091" }, { "nct_id": "NCT04410198", "title": "Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia Associated With End Stage Renal Disease (ESRD)" ], "interventions": [ { "name": "Roxadustat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyntra Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 203, "start_date": "2020-05-26", "completion_date": "2021-10-11", "has_results": true, "last_update_posted_date": "2022-09-13", "last_synced_at": "2026-10-01T02:07:39.216Z", "location_count": 9, "location_summary": "Englewood, Colorado • Caldwell, Idaho • Baton Rouge, Louisiana + 6 more", "locations": [ { "city": "Englewood", "state": "Colorado" }, { "city": "Caldwell", "state": "Idaho" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Kalamazoo", "state": "Michigan" }, { "city": "Tupelo", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT04410198" } ] }